Skip to Content
Get key facts and figures about chronic dry eye

Drug interactions between Camptosar and Diamox

Results for the following 2 drugs:
Camptosar (irinotecan)
Diamox (acetazolamide)

Interactions between your drugs

Moderate

acetaZOLAMIDE irinotecan

Applies to: Diamox (acetazolamide) and Camptosar (irinotecan)

Using irinotecan together with acetaZOLAMIDE may increase the risk of dehydration and electrolyte abnormalities. Irinotecan can cause severe vomiting and diarrhea, which leads to water and electrolyte loss from the body that may be worsened with the use of a diuretic. Talk to your doctor if you have any questions or concerns. You should seek prompt medical attention if you experience vomiting or diarrhea that is not responsive to medications. In severe cases, dehydration and electrolyte abnormalities can lead to irregular heart rhythm, seizures, and kidney problems. Contact your doctor if you experience potential signs and symptoms of fluid and electrolyte depletion such as dizziness, lightheadedness, dry mouth, thirst, fatigue, weakness, muscle cramps, decreased urination, palpitation, and increased heart rate. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide